Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-25-021423

Options or other derivatives

  • Director acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pande Vijay Satyanand · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +22,000 22,000 D
Loading xslF345X05/form4-08112025_080820.xml…